Xuriden 2 GM Oral Granules

RxCUI: 1665473
RxNorm name: Xuriden 2 GM Oral Granules
Display name: Xuriden 2 GM Oral Granules
Full name: Xuriden 2 GM Oral Granules
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
XURIDEN	URIDINE TRIACETATE	BTG International Inc	88ca4d2b-3905-474b-9fd6-c81474f2fb4b	2025-02-18	Warnings, Adverse reactions	Exact identifier rxcui: 1665473

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
88ca4d2b-3905-474b-9fd6-c81474f2fb4b	Xuriden 2 GM Oral Granules	SY	4	These highlights do not include all the information needed to use XURIDEN safely and effectively. See full prescribing information for XURIDEN. XURIDEN® (uridine triacetate) oral granules Initial U.S. Approval: 2015	20250218
88ca4d2b-3905-474b-9fd6-c81474f2fb4b	Xuriden 2 GM Oral Granules	PSN	4	These highlights do not include all the information needed to use XURIDEN safely and effectively. See full prescribing information for XURIDEN. XURIDEN® (uridine triacetate) oral granules Initial U.S. Approval: 2015	20250218
88ca4d2b-3905-474b-9fd6-c81474f2fb4b	uridine triacetate 2000 MG Oral Granules [Xuriden]	SBD	4	These highlights do not include all the information needed to use XURIDEN safely and effectively. See full prescribing information for XURIDEN. XURIDEN® (uridine triacetate) oral granules Initial U.S. Approval: 2015	20250218